eli lilly gip glp-1 use tripled among non-diabetics, reaching $5.8B in 2022 Novo Nordisk, Eli Lilly make
Description
The results revealed that confirmed NAION cases were extremely rare, with only three cases in the treated group and five cases in the placebo group.
A boxed or black box warning is a serious warning given by the FDA for drugs or drug classes that may cause serious harm or death
A population-based cohort study of nearly 114,000 patients with T2D found that use of GLP-1s, compared with SGLT-2 inhibitors, was associated with a 27% higher relative risk of being diagnosed with GERD and a 55% higher relative risk of GERD-related complications
Curious about microdosing Tirzepatide
Read the enclosed brochure for other important information
PlexusDx provides personalized semaglutide therapy with medical oversight for comprehensive metabolic health
